Steven Robert Alberts, MD

  • 14918 Citations
  • 52 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1987 2019

  • 14918 Citations
  • 52 Scopus h-Index
  • 200 Article
  • 3 Chapter
  • 3 Review article
  • 2 Letter
Filter
Article
2019
1 Citation (Scopus)

A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)

Halfdanarson, T. R., Foster, N. R., Kim, G. P., Meyers, J. P., Smyrk, T. C., McCullough, A. E., Ames, M. M., Jaffe, J. P. & Alberts, S. R., Jan 1 2019, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

gemcitabine
Adenocarcinoma
Epidermal Growth Factor Receptor
Neoplasms
Survival

Combined Celiac Ganglia and Plexus Neurolysis Shortens Survival, Without Benefit, vs Plexus Neurolysis Alone

Levy, M. J., Gleeson, F. C., Topazian, M., Fujii-Lau, L. L., Enders, F. T., Larson, J. J., Mara, K., Abu Dayyeh, B. K., Alberts, S. R., Hallemeier, C., Iyer, P. G., Kendrick, M. L., Mauck, W. D., Pearson, R. K., Petersen, B. T., Rajan, E., Takahashi, N. M., Vege, S. S., Wang, K. K. N. & Chari, S. T., Mar 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 4, p. 728-738.e9

Research output: Contribution to journalArticle

Celiac Plexus
Sympathetic Ganglia
Survival
Pain
Quality of Life
6 Citations (Scopus)

Hepatobiliary cancers, version 2.2019 featured updates to the NCCN guidelines

Benson, A. B., D'Angelica, M. I., Abbott, D. E., Abrams, T. A., Alberts, S. R., Anaya, D. A., Anders, R., Are, C., Brown, D., Chang, D. T., Cloyd, J., Covey, A. M., Hawkins, W., Iyer, R., Jacob, R., Karachristos, A., Kate Kelley, R., Kim, R., Palta, M., Park, J. O. & 11 others, Sahai, V., Schefter, T., Sicklick, J. K., Singh, G., Sohal, D., Stein, S., Gary Tian, G., Vauthey, J. N., Venook, A. P., Hammond, L. J. & Darlow, S. D., Apr 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 4, p. 302-310 9 p.

Research output: Contribution to journalArticle

Open Access
Guidelines
Gallbladder Neoplasms
Neoplasms
Liver Neoplasms
Bile Ducts
3 Citations (Scopus)

Intertumoral heterogeneity of CD3þ and CD8þ T-cell densities in the microenvironment of DNA mismatch-repair–deficient colon cancers: Implications for prognosis

Yoon, H. H., Shi, Q. D., Heying, E. N., Muranyi, A., Bredno, J., Ough, F., Djalilvand, A., Clements, J., Bowermaster, R., Liu, W. W., Barnes, M., Alberts, S. R., Shanmugam, K. & Sinicrope, F. A., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 125-133 9 p.

Research output: Contribution to journalArticle

DNA Mismatch Repair
Colonic Neoplasms
Cell Count
T-Lymphocytes
DNA
1 Citation (Scopus)

Marine omega-3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance)

Song, M., Ou, F-S., Zemla, T. J., Hull, M. A., Shi, Q. D., Limburg, P. J., Alberts, S. R., Sinicrope, F. A., Giovannucci, E. L., Van Blarigan, E. L., Meyerhardt, J. A. & Chan, A. T., Jan 1 2019, (Accepted/In press) In : International Journal of Cancer.

Research output: Contribution to journalArticle

DNA Mismatch Repair
Omega-3 Fatty Acids
Tumor Biomarkers
Unsaturated Fatty Acids
Colonic Neoplasms
1 Citation (Scopus)

Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: Results of an ACCENT pooled analysis of seven studies

Taieb, J., Shi, Q., Pederson, L., Alberts, S., Wolmark, N., Van Cutsem, E., De Gramont, A., Kerr, R., Grothey, A., Lonardi, S., Yoshino, T., Yothers, G., Sinicrope, F. A., Zaanan, A. & André, T., Sep 1 2019, In : Annals of Oncology. 30, 9, p. 1466-1471 6 p.

Research output: Contribution to journalArticle

Microsatellite Instability
Microsatellite Repeats
Colonic Neoplasms
DNA Mismatch Repair
Recurrence
2018
1 Citation (Scopus)

Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma

Kommalapati, A., Tella, S. H., Goyal, G., Borad, M. J., Alberts, S. R., Roberts, L. R., Hubbard, J. M., Durgin, L., Cleary, S. & Mahipal, A., Jan 1 2018, (Accepted/In press) In : HPB.

Research output: Contribution to journalArticle

Cholangiocarcinoma
Survival
Liver
Therapeutics
Insurance
1 Citation (Scopus)

Gastric cancer in Alaska Native people: A cancer health disparity

Martinson, H. A., Shelby, N. J., Alberts, S. R. & Olnes, M. J., Jul 7 2018, In : World Journal of Gastroenterology. 24, 25, p. 2722-2732 11 p.

Research output: Contribution to journalArticle

Stomach Neoplasms
Health
Neoplasms
Survival
Alaska Natives
8 Citations (Scopus)

Phase i dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer

Kim, R. D., Alberts, S. R., Peña, C., Genvresse, I., Ajavon-Hartmann, A., Xia, C., Kelly, A. & Grilley-Olson, J. E., Feb 20 2018, In : British Journal of Cancer. 118, 4, p. 462-470 9 p.

Research output: Contribution to journalArticle

gemcitabine
Cisplatin
Biliary Tract Neoplasms
Neoplasms
Phosphatidylinositol 3-Kinase

Physical activity and outcomes in patients with stage III colon cancer: A correlative analysis of phase III trial NCCTG N0147 (Alliance)

Phipps, A. I., Shi, Q. D., Zemla, T. J., Dotan, E., Gill, S., Goldberg, R. M., Hardikar, S., Jahagirdar, B., Limburg, P. J., Newcomb, P. A., Shields, A., Sinicrope, F. A., Sargent, D. J. & Alberts, S. R., Jun 1 2018, In : Cancer Epidemiology Biomarkers and Prevention. 27, 6, p. 696-703 8 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Exercise
Survival
Neoplasms
Confidence Intervals
3 Citations (Scopus)

Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience

Jin, Z., Hartgers, M. L., Sanhueza, C. T., Shubert, C. R., Alberts, S. R., Truty, M., Muppa, P., Nagorney, D. M., Smyrk, T. C., Hassan, M. & Mahipal, A., Jan 1 2018, (Accepted/In press) In : European Journal of Surgical Oncology.

Research output: Contribution to journalArticle

Pancreaticoduodenectomy
Adenocarcinoma
Therapeutics
Survival
Multivariate Analysis
18 Citations (Scopus)

Role of deficient DNA mismatch repair status in patients with stage III colon cancer treated with FOLFOX adjuvant chemotherapy a pooled analysis from 2 randomized clinical trials

Zaanan, A., Shi, Q. D., Taieb, J., Alberts, S. R., Meyers, J. P., Smyrk, T. C., Julie, C., Zawadi, A., Tabernero, J., Mini, E., Goldberg, R. M., Folprecht, G., Van Laethem, J. L., Le Malicot, K., Sargent, D. J., Laurent-Puig, P. & Sinicrope, F. A., Mar 1 2018, In : JAMA oncology. 4, 3, p. 379-383 5 p.

Research output: Contribution to journalArticle

oxaliplatin
DNA Repair-Deficiency Disorders
DNA Mismatch Repair
Leucovorin
Adjuvant Chemotherapy
4 Citations (Scopus)

Survival and Prognostic Factors in Patients with Solid Pseudopapillary Neoplasms of the Pancreas

Huffman, B. M., Westin, G., Alsidawi, S., Alberts, S. R., Nagorney, D. M., Halfdanarson, T. R. & Mahipal, A., Sep 1 2018, In : Pancreas. 47, 8, p. 1003-1007 5 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Survival
Neoplasms
Multivariate Analysis
Databases
2017
31 Citations (Scopus)

Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)

Fuchs, C. S., Niedzwiecki, D., Mamon, H. J., Tepper, J. E., Ye, X., Swanson, R. S., Enzinger, P. C., Haller, D. G., Dragovich, T., Alberts, S. R., Bjarnason, G. A., Willett, C. G., Gunderson, L. L., Alberts, S. R., Venook, A. P., Ilson, D., O'Reilly, E., Ciombor, K., Berg, D. J., Meyerhardt, J. & 1 others, Mayer, R. J., Nov 10 2017, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35, 32, p. 3671-3677 7 p.

Research output: Contribution to journalArticle

Adjuvant Chemoradiotherapy
Epirubicin
Leucovorin
Fluorouracil
Cisplatin
36 Citations (Scopus)

Association of DNA mismatch repair and mutations in BRAF and KRAS with survival after recurrence in stage III colon cancers: A secondary analysis of 2 randomized clinical trials

Sinicrope, F. A., Shi, Q. D., Allegra, C. J., Smyrk, T. C., Thibodeau, S. N., Goldberg, R. M., Meyers, J. P., Pogue-Geile, K. L., Yothers, G., Sargent, D. J. & Alberts, S. R., 2017, In : JAMA oncology. 3, 4, p. 472-480 9 p.

Research output: Contribution to journalArticle

DNA Mismatch Repair
Colonic Neoplasms
Randomized Controlled Trials
Recurrence
Mutation
2 Citations (Scopus)

Family history of colorectal cancer and its impact on survival in patients with resected stage III colon cancer: Results from NCCTG Trial N0147 (Alliance)

Jansson-Knodell, C. L., Foster, N. R., Sargent, D. J., Limburg, P. J., Thibodeau, S. N., Smyrk, T. C., Sinicrope, F. A., Jahagirdar, B., Goldberg, R. M. & Alberts, S. R., 2017, In : Journal of Gastrointestinal Oncology. 8, 1, p. 1-11 11 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Colorectal Neoplasms
Survival
Disease-Free Survival
Confidence Intervals
25 Citations (Scopus)

MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer

Miyoshi, J., Toden, S., Yoshida, K., Toiyama, Y., Alberts, S. R., Kusunoki, M., Sinicrope, F. A. & Goel, A., Mar 6 2017, In : Scientific Reports. 7, 43393.

Research output: Contribution to journalArticle

MicroRNAs
Colorectal Neoplasms
Biomarkers
Neoplasm Metastasis
Recurrence
35 Citations (Scopus)

Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study

Dienstmann, R., Mason, M. J., Sinicrope, F. A., Phipps, A. I., Tejpar, S., Nesbakken, A., Danielsen, S. A., Sveen, A., Buchanan, D. D., Clendenning, M., Rosty, C., Bot, B., Alberts, S. R., Milburn Jessup, J., Lothe, R. A., Delorenzi, M., Newcomb, P. A., Sargent, D. & Guinney, J., May 1 2017, In : Annals of oncology : official journal of the European Society for Medical Oncology. 28, 5, p. 1023-1031 9 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Biomarkers
Survival
Microsatellite Instability
Neoplasm Staging
52 Citations (Scopus)

Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer

Taieb, J., Le Malicot, K., Shi, Q. D., Lorca, F. P., Bouché, O., Tabernero, J., Mini, E., Goldberg, R. M., Folprecht, G., Van Laethem, J. L., Sargent, D. J., Alberts, S. R., Emile, J. F., Puig, P. L. & Sinicrope, F. A., May 1 2017, In : Journal of the National Cancer Institute. 109, 5, djw272.

Research output: Contribution to journalArticle

Microsatellite Repeats
Colonic Neoplasms
Mutation
Confidence Intervals
Recurrence
2016
9 Citations (Scopus)

Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147

Phipps, A. I., Shi, Q. D., Limburg, P. J., Nelson, G. D., Sargent, D. J., Sinicrope, F. A., Chan, E., Gill, S., Goldberg, R. M., Kahlenberg, M., Nair, S., Shields, A. F., Newcomb, P. A. & Alberts, S. R., 2016, (Accepted/In press) In : International Journal of Cancer.

Research output: Contribution to journalArticle

Alcohol Drinking
Colonic Neoplasms
Wine
Disease-Free Survival
Neoplasms
26 Citations (Scopus)

Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein

Wang, Y., Ding, X., Wang, S., Moser, C. D., Shaleh, H. M., Mohamed, E. A., Chaiteerakij, R., Allotey, L. K., Chen, G., Miyabe, K., McNulty, M. S., Ndzengue, A., Barr Fritcher, E. G., Knudson, R. A., Greipp, P. T., Clark, K. J., Torbenson, M., Kipp, B. R., Zhou, J., Barrett, M. & 4 others, Gustafson, M., Alberts, S. R., Borad, M. J. & Roberts, L. R., Sep 28 2016, In : Cancer Letters. 380, 1, p. 163-173 11 p.

Research output: Contribution to journalArticle

Receptor, Fibroblast Growth Factor, Type 2
Cholangiocarcinoma
Heterografts
Proteins
Neoplasms
16 Citations (Scopus)

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Lee, A. M., Shi, Q. D., Alberts, S. R., Sargent, D. J., Sinicrope, F. A., Berenberg, E. L., Grothey, A. F., Polite, B., Chan, E., Gill, S., Kahlenberg, M. S., Nair, S. G., Shields, A. F., Goldberg, R. M. & Diasio, R. B., 2016, In : Pharmacogenetics and Genomics. 26, 3, p. 133-137 5 p.

Research output: Contribution to journalArticle

Fluorouracil
Colonic Neoplasms
Drug Therapy
Poisons
Combination Drug Therapy
9 Citations (Scopus)

Determinants of earlymortality among 37,568 patientswith colon cancerwho participated in 25 clinical trials from the adjuvant colon cancer endpoints database

Cheung, W. Y., Renfro, L. A., Kerr, D., De Gramont, A., Saltz, L. B., Grothey, A. F., Alberts, S. R., Andre, T., Guthrie, K. A., Labianca, R., Francini, G., Seitz, J. F., O'Callaghan, C., Twelves, C., Van Cutsem, E., Haller, D. G., Yothers, G. & Sargent, D. J., Apr 10 2016, In : Journal of Clinical Oncology. 34, 11, p. 1182-1189 8 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Colon
Clinical Trials
Databases
Mortality
15 Citations (Scopus)

EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer

Levy, M. J., Alberts, S. R., Bamlet, W. R., Burch, P. A., Farnell, M. B., Gleeson, F. C., Haddock, M., Kendrick, M. L., Oberg, A. L., Petersen, G. M., Takahashi, N. & Chari, S. T., Jul 21 2016, (Accepted/In press) In : Gastrointestinal Endoscopy.

Research output: Contribution to journalArticle

gemcitabine
Pancreatic Neoplasms
Needles
Injections
Survival
37 Citations (Scopus)

Impact of patient factors on recurrence risk and time dependency of oxaliplatin benefit in patients with colon cancer: Analysis from modern-era adjuvant studies in the adjuvant colon cancer end points (ACCENT) database

Shah, M. A., Renfro, L. A., Allegra, C. J., André, T., De Gramont, A., Schmoll, H. J., Haller, D. G., Alberts, S. R., Yothers, G. & Sargent, D. J., Mar 10 2016, In : Journal of Clinical Oncology. 34, 8, p. 843-853 11 p.

Research output: Contribution to journalArticle

oxaliplatin
Colonic Neoplasms
Databases
Recurrence
Therapeutics
4 Citations (Scopus)
Hepatocellular Carcinoma
Maximum Tolerated Dose
Neoplasms
Therapeutics
Hypophosphatemia
50 Citations (Scopus)

Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial

Yoon, H. H., Bendell, J. C., Braiteh, F. S., Firdaus, I., Philip, P. A., Cohn, A. L., Lewis, N., Anderson, D. M., Arrowsmith, E., Schwartz, J. D., Gao, L., Hsu, Y., Xu, Y., Ferry, D., Alberts, S. R. & Wainberg, Z. A., Dec 1 2016, In : Annals of oncology : official journal of the European Society for Medical Oncology. 27, 12, p. 2196-2203 8 p.

Research output: Contribution to journalArticle

Esophagogastric Junction
Stomach
Adenocarcinoma
Disease-Free Survival
Therapeutics
12 Citations (Scopus)

Relationship between metformin use and recurrence and survival in patients with resected stage III colon cancer receiving adjuvant chemotherapy: Results from north central cancer treatment group N0147 (Alliance)

Singh, P. P., Shi, Q. D., Foster, N. R., Grothey, A. F., Nair, S. G., Chan, E., Shields, A. F., Goldberg, R. M., Gill, S., Kahlenberg, M. S., Sinicrope, F. A., Sargent, D. J. & Alberts, S. R., Dec 1 2016, In : Oncologist. 21, 12, p. 1509-1512 4 p.

Research output: Contribution to journalArticle

Metformin
Adjuvant Chemotherapy
Colonic Neoplasms
Recurrence
Survival
28 Citations (Scopus)

Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People

Redwood, D. G., Asay, E. D., Blake, I. D., Sacco, P. E., Christensen, C. M., Sacco, F. D., Tiesinga, J. J., Devens, M. E., Alberts, S. R., Mahoney, D. W., Yab, T. C., Foote, P. H., Smyrk, T. C., Provost, E. M. & Ahlquist, D. A., Jan 1 2016, In : Mayo Clinic Proceedings. 91, 1, p. 61-70 10 p.

Research output: Contribution to journalArticle

Hemoglobins
DNA
Colonoscopy
Colorectal Neoplasms
Neoplasms
3 Citations (Scopus)

Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database

Papamichael, D., Renfro, L. A., Matthaiou, C., Yothers, G., Saltz, L., Guthrie, K. A., Van Cutsem, E., Schmoll, H. J., Labianca, R., André, T., O'Connell, M., Alberts, S. R., Haller, D. G., Kountourakis, P. & Sargent, D. J., Mar 16 2016, (Accepted/In press) In : Journal of Geriatric Oncology.

Research output: Contribution to journalArticle

Colonic Neoplasms
Databases
Morbidity
Survival
Recurrence
2015
30 Citations (Scopus)

Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)

for the Alliance for Clinical Trials in Oncology & Sargent, D. J., Dec 1 2015, In : Clinical Cancer Research. 21, 23, p. 5294-5304 11 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Tumor Biomarkers
Colon
Carcinoma
Neoplasms
11 Citations (Scopus)

Improving adherence to cancer treatment by addressing quality of life in patients with advanced gastrointestinal cancers

Cheville, A. L., Alberts, S. R., Rummans, T. A., Basford, J. R., Lapid, M. I., Sloan, J. A., Satele, D. V. & Clark, M. M., Sep 1 2015, In : Journal of Pain and Symptom Management. 50, 3, p. 321-327 7 p.

Research output: Contribution to journalArticle

Gastrointestinal Neoplasms
Quality of Life
Hospitalization
Neoplasms
Therapeutics
14 Citations (Scopus)

Low level of hepatitis b virus screening among patients receiving chemotherapy

Wi, C. I., Loo, N. M., Larson, J. J., Moynihan, T. J., Madde, N. R., Grendahl, D. C., Alberts, S. R. & Kim, W. R., May 1 2015, In : Clinical Gastroenterology and Hepatology. 13, 5, p. 970-975 6 p.

Research output: Contribution to journalArticle

Hepatitis Viruses
Drug Therapy
Hepatitis B virus
Virus Diseases
Hematologic Neoplasms
33 Citations (Scopus)

MiR-320e is a novel prognostic biomarker in colorectal cancer

Perez-Carbonell, L., Sinicrope, F. A., Alberts, S. R., Oberg, A. L., Balaguer, F., Castells, A., Boland, C. R. & Goel, A., Jun 30 2015, In : British Journal of Cancer. 113, 1, p. 83-90 8 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Biomarkers
MicroRNAs
oxaliplatin
Recurrence
165 Citations (Scopus)

Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes

Sinicrope, F. A., Shi, Q. D., Smyrk, T. C., Thibodeau, S. N., Dienstmann, R., Guinney, J., Bot, B. M., Tejpar, S., Delorenzi, M., Goldberg, R. M., Mahoney, M., Sargent, D. J. & Alberts, S. R., Jan 1 2015, In : Gastroenterology. 148, 1, p. 88-99 12 p.

Research output: Contribution to journalArticle

DNA Mismatch Repair
Colonic Neoplasms
Mutation
Neoplasms
Disease-Free Survival
3 Citations (Scopus)

Portal vein encasement predicts neoadjuvant therapy response in liver transplantation for perihilar cholangiocarcinoma protocol

Bhat, M., Hathcock, M., Kremers, W. K., Darwish Murad, S., Schmit, G., Martenson, J., Alberts, S. R., Rosen, C. B., Gores, G. J. & Heimbach, J., Dec 1 2015, In : Transplant International. 28, 12, p. 1383-1391 9 p.

Research output: Contribution to journalArticle

Klatskin Tumor
Neoadjuvant Therapy
Cholangiocarcinoma
Portal Vein
Liver Transplantation
3 Citations (Scopus)

Prospective Evaluation of a 12-Gene Assay on Patient Treatment Decisions and Physician Confidence in Mismatch Repair Proficient Stage IIA Colon Cancer

Renfro, L. A., Zhang, N., Lopatin, M., Chao, C. & Alberts, S. R., Aug 29 2015, (Accepted/In press) In : Clinical Colorectal Cancer.

Research output: Contribution to journalArticle

DNA Mismatch Repair
Colonic Neoplasms
Physicians
Genes
Therapeutics
36 Citations (Scopus)
Mutation Rate
Colonic Neoplasms
Survival
Neoplasms
Adjuvant Chemotherapy
6 Citations (Scopus)

Survival following early-stage colon cancer: An ACCENT-based comparison of patients versus a matched international general population

for the Adjuvant Colon Cancer Endpoints (ACCENT) Group & Sargent, D. J., May 1 2015, In : Annals of Oncology. 26, 5, p. 950-958 9 p., mdv073.

Research output: Contribution to journalArticle

Colonic Neoplasms
Survival
Population
oxaliplatin
Recurrence
88 Citations (Scopus)

SWOG S0809: A phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma

Ben-Josef, E., Guthrie, K. A., El-Khoueiry, A. B., Corless, C. L., Zalupski, M. M., Lowy, A. M., Thomas, C. R., Alberts, S. R., Dawson, L. A., Micetich, K. C., Thomas, M. B., Siegel, A. B. & Blanke, C. D., Aug 20 2015, In : Journal of Clinical Oncology. 33, 24, p. 2617-2622 6 p.

Research output: Contribution to journalArticle

gemcitabine
Cholangiocarcinoma
Gallbladder
Radiotherapy
Carcinoma
2014
27 Citations (Scopus)

ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer

The Adjuvant Colon Cancer Endpoints (ACCENT) Group & Sargent, D. J., Dec 1 2014, In : Journal of the National Cancer Institute. 106, 12, dju333.

Research output: Contribution to journalArticle

Colonic Neoplasms
Recurrence
Survival
Neoplasms
Phase III Clinical Trials
32 Citations (Scopus)
3' Untranslated Regions
MicroRNAs
Colonic Neoplasms
Genotype
Clinical Trials
8 Citations (Scopus)

Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer

Alberts, S. R., Yu, T. M., Behrens, R. J., Renfro, L. A., Srivastava, G., Soori, G. S., Dakhil, S. R., Mowat, R. B., Kuebler, J. P., Kim, G. P., Mazurczak, M. A. & Hornberger, J., Nov 26 2014, In : PharmacoEconomics. 32, 12, p. 1231-1243 13 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Colonic Neoplasms
Economics
Costs and Cost Analysis
Recurrence
30 Citations (Scopus)

Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147

Huang, J., Nair, S. G., Mahoney, M. R., Nelson, G. D., Shields, A. F., Chan, E., Goldberg, R. M., Gill, S., Kahlenberg, M. S., Quesenberry, J. T., Thibodeau, S. N., Smyrk, T. C., Grothey, A. F., Sinicrope, F. A., Webb, T. A., Farr, G. H., Pockaj, B. A., Berenberg, J. L., Mooney, M., Sargent, D. J. & 1 others, Alberts, S. R., 2014, In : Clinical Colorectal Cancer. 13, 2, p. 100-109 10 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Disease-Free Survival
Neoplasms
irinotecan
Therapeutics
73 Citations (Scopus)

DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147)

Lee, A. M., Shi, Q. D., Pavey, E., Alberts, S. R., Sargent, D. J., Sinicrope, F. A., Berenberg, J. L., Goldberg, R. M. & Diasio, R. B., Dec 1 2014, In : Journal of the National Cancer Institute. 106, 12, dju298.

Research output: Contribution to journalArticle

Fluorouracil
Colonic Neoplasms
Neutropenia
Therapeutics
Odds Ratio
8 Citations (Scopus)

Historical controls for metastatic pancreatic cancer: Benchmarks for planning and analyzing single-arm phase II trials

Philip, P. A., Chansky, K., LeBlanc, M., Rubinstein, L., Seymour, L., Ivy, S. P., Alberts, S. R., Catalano, P. J. & Crowley, J., Aug 15 2014, In : Clinical Cancer Research. 20, 16, p. 4176-4185 10 p.

Research output: Contribution to journalArticle

Benchmarking
Pancreatic Neoplasms
Disease-Free Survival
gemcitabine
Survival
36 Citations (Scopus)

Improved time to treatment failure with an intermittent oxaliplatin strategy: Results of CONcePT

Hochster, H. S., Grothey, A. F., Hart, L., Rowland, K., Ansari, R., Alberts, S. R., Chowhan, N., Ramanathan, R. K., Keaton, M., Hainsworth, J. D. & Childs, B. H., 2014, In : Annals of Oncology. 25, 6, p. 1172-1178 7 p.

Research output: Contribution to journalArticle

oxaliplatin
Treatment Failure
Magnesium
Salts
Calcium
68 Citations (Scopus)

KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance)

Yoon, H. H., Tougeron, D., Shi, Q. D., Alberts, S. R., Mahoney, M. R., Nelson, G. D., Nair, S. G., Thibodeau, S. N., Goldberg, R. M., Sargent, D. J. & Sinicrope, F. A., Jun 1 2014, In : Clinical Cancer Research. 20, 11, p. 3033-3043 11 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Codon
Colonic Neoplasms
Disease-Free Survival
Mutation
3 Citations (Scopus)

Outcome of transplant-fallout patients with unresectable cholangiocarcinoma

Sio, T. T., Martenson, J. A., Haddock, M., Novotny, P. J., Gores, G. J., Alberts, S. R., Miller, R. C., Heimbach, J. K. & Rosen, C. B., Jun 11 2014, (Accepted/In press) In : American Journal of Clinical Oncology: Cancer Clinical Trials.

Research output: Contribution to journalArticle

Cholangiocarcinoma
Liver Transplantation
Transplants
Survival
Licensure
74 Citations (Scopus)

Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147

Gonsalves, W., Mahoney, M. R., Sargent, D. J., Nelson, G. D., Alberts, S. R., Sinicrope, F. A., Goldberg, R. M., Limburg, P. J., Thibodeau, S. N., Grothey, A. F., Hubbard, J. M., Chan, E., Nair, S., Berenberg, J. L. & Mc Williams, R. R., Jul 9 2014, In : Journal of the National Cancer Institute. 106, 7, dju106.

Research output: Contribution to journalArticle

Colonic Neoplasms
Mutation
DNA Mismatch Repair
Neoplasms
Odds Ratio